Proton therapy boosts survival for recurrent head, neck cancer

A new study out of Spain shows proton therapy significantly improves survival rates for recurrent head and neck cancer patients. It hit a 67% one-year overall survival rate for people previously treated with radiation. This offers a new option for patients whose nervous system is already stressed from previous treatments.